A summary of the key achievements between January and March 2016 is provided below:
Scale-up of integrated HIV services had reached the following number of sites:
724 static (579 within, 145 outside of health facilities) and 188 outreach HTC sites
724 (static) ART sites
631 PMTCT sites (Option B+, all included in ART sites above)
661 Pre-ART sites
653 sites with HIV-exposed child follow-up
862,157 persons were tested for HIV and received their results; 270,252 (31%)
accessed HTC for the first time; 591,905 (69%) were repeat testers and 30,048 (5%)
of these received confirmatory testing (after having tested positive in the past).
41,901 (5%) clients received a positive result for the first time.
22,727 (97%) of 23,335 blood units collected were screened for (at least) HIV,
hepatitis B and syphilis.
147,765 (95%) of 156,222 women at ANC had their HIV status ascertained; 11,567
(9%) of these were HIV positive. 120,777 (98%) of 123,203 women at maternity had
their HIV status ascertained 9,408 (8%) of these were HIV positive.
28,052 patients started ART this quarter.
611,031 patients were alive and on ART by end of March 2016. This means that 62%
of the estimated 979,000 HIV positive population was on ART. 1 ART coverage was
61% (49,672 / 81,000) for children and 63% (561,359 / 898,000) for adults.
76% of adults and 74% of children were retained alive on ART at 12 months after
initiation. Actual retention rates are thought to be about 10% higher due to
misclassification of ‘silent transfers’ as defaulters in clinic-based survival/retention
analysis. (see section 15.4)
532,156 (93%) of 599,315 patients on first line adult ART were on regimen 5A
11,715 3 (87%) of an estimated 13,500 HIV infected pregnant women in Malawi
were on ART this quarter. 7,074 (60%) of these were already on ART when getting
pregnant and 4,641 (40%) started ART during pregnancy/delivery.
An additional 1,864 breastfeeding women started ART due to Option B+ (in WHO
75%, 69%, 66% and 65% of women started under Option B+ were retained on ART at
6, 12, 24 and 36 months after initiation, respectively.
8,784 (8%) of infants discharged alive from maternity were known to be HIV
exposed, 8,332 (95%) of these received ARV prophylaxis (nevirapine). 8,329 (95%)
were enrolled in exposed child follow-up before age 2 months.
12,296 HIV exposed children and 7,047 pre-ART patients were enrolled for follow-up
in HIV Care Clinics (HCC) during this quarter.